Treatment with ALK TKIs was significantly associated with ILD, with ROR (4.58, 95% CI 4.23–4.96), PRR (4.47), IC (2.15, IC025 1.99–2.33), and EBGM (4.45, 95% CI 4.16–4.75). The gene discussed is ALK; the disease is interstitial lung disease.